FASCIOLIASIS

Clinical trials for FASCIOLIASIS explained in plain language.

Never miss a new study

Get alerted when new FASCIOLIASIS trials appear

Sign up with your email to follow new studies for FASCIOLIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 1

Could one dose beat two? new trial aims to simplify parasite treatment

Disease control Not yet recruiting

This study compares a new drug, oxfendazole, given as one or two doses, against the standard two-dose treatment with triclabendazole for chronic fascioliasis, a parasitic liver infection. About 336 adults in rural Peru will take part. The goal is to see if oxfendazole works just …

Matched conditions: FASCIOLIASIS

Phase: PHASE2 • Sponsor: Universidad Peruana Cayetano Heredia • Aim: Disease control

Last updated May 22, 2026 13:52 UTC

FASCIOLIASIS

Get alerted when new FASCIOLIASIS trials appear

Could one dose beat two? new trial aims to simplify parasite treatment